Effective December 1, 2022: Pharmacy and Biopharmacy Policies
Superior HealthPlan has added or updated certain pharmacy and biopharmacy policies to ensure medical necessity review criteria is current and appropriate for members and the scope of services provided. As a result, the following policies are effective on December 1, 2022 at 12:00AM.
NEW POLICY OVERVIEW OR UPDATED POLICY REVISIONS
Efgartigimod Alfa-fcab (Vyvgart) (CP.PHAR.555)
Medicaid (STAR, STAR Health, STAR Kids, STAR+PLUS), CHIP, and Ambetter
Policy updates include:
To review all policies, please visit Superior’s Clinical, Payment & Pharmacy Policies webpage.
Prior to updates, pharmacy and biopharmacy clinical policies are reviewed and approved by the Pharmacy and Therapeutics (P&T) Committee.
For questions or additional information, please contact Superior’s Pharmacy Department at 1-800-218-7453, ext. 22272.